blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4013740

EP4013740 - LIPIDS FOR DELIVERY OF CHARGED MATERIAL, FORMULATIONS THEREOF AND METHOD FOR MAKING SAME [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  20.05.2022
Database last updated on 24.08.2024
FormerThe international publication has been made
Status updated on  19.02.2021
Most recent event   Tooltip05.07.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Integrated Nanotherapeutics Inc.
Suite 205
4475 Wayburne Drive
Burnaby BC V5G 4X4 / CA
For all designated states
The University of British Columbia
University - Industry Liaison Office
103-6190 Agronomy Road
Vancouver, British Columbia V6T 1Z3 / CA
[2022/25]
Inventor(s)01 / ZAIFMAN, Joshua
c/o Integrated Nanotherapeutics Inc. Suite 205,
4475 Wayburne Drive
Burnaby, BC V5G 4X4 / CA
02 / CHEN, Sam
c/o Integrated Nanotherapeutics Inc. Suite 205,
4475 Wayburne Drive
Burnaby, BC V5G 4X4 / CA
03 / TAM, Yuen Yi
c/o Integrated Nanotherapeutics Inc. Suite 205,
4475 Wayburne Drive
Burnaby, BC V5G 4X4 / CA
04 / CIUFOLINI, Marco A.
c/o Integrated Nanotherapeutics Inc. Suite 205,
4475 Wayburne Drive
Burnaby, BC V5G 4X4 / CA
 [2022/25]
Representative(s)Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
[2022/25]
Application number, filing date20851380.411.08.2020
[2022/25]
WO2020CA51098
Priority number, dateUS201962885677P12.08.2019         Original published format: US 201962885677 P
[2022/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021026647
Date:18.02.2021
Language:EN
[2021/07]
Type: A1 Application with search report 
No.:EP4013740
Date:22.06.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 18.02.2021 takes the place of the publication of the European patent application.
[2022/25]
Search report(s)International search report - published on:CA18.02.2021
(Supplementary) European search report - dispatched on:EP23.08.2023
ClassificationIPC:C07C219/06, A61K47/18, A61K47/22, A61K9/14, C07C217/40, C07C219/08, C07C219/12, C07C229/12, C07C237/08, C07D317/28, C07D493/08, C12N15/113, C12N15/87
[2022/25]
CPC:
C07C237/10 (EP,KR); C07C219/08 (EP,KR); A61K9/1272 (EP,KR,US);
A61K47/14 (KR); A61K47/22 (KR); A61K9/5123 (EP,KR);
C07C217/08 (EP,KR); C07C219/06 (EP,US); C07C219/12 (EP);
C07C229/12 (EP); C07C309/12 (EP); C07C309/67 (US);
C07C309/68 (US); C07C69/675 (US); C07C69/732 (US);
C07D317/28 (EP,KR); C07D317/72 (EP,KR); C07D493/08 (EP,KR);
C12N15/111 (EP); C12N15/88 (EP); C07C2602/14 (EP);
C12N2320/32 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/25]
TitleGerman:LIPIDE ZUR ABGABE VON GELADENEM MATERIAL, FORMULIERUNGEN DAVON UND VERFAHREN ZU IHRER HERSTELLUNG[2022/25]
English:LIPIDS FOR DELIVERY OF CHARGED MATERIAL, FORMULATIONS THEREOF AND METHOD FOR MAKING SAME[2022/25]
French:LIPIDES POUR L'ADMINISTRATION D'UN MATÉRIAU CHARGÉ, LEURS FORMULATIONS ET LEUR PROCÉDÉ DE FABRICATION[2022/25]
Entry into regional phase11.03.2022National basic fee paid 
11.03.2022Search fee paid 
11.03.2022Designation fee(s) paid 
11.03.2022Examination fee paid 
Examination procedure11.01.2021Request for preliminary examination filed
International Preliminary Examining Authority: CA
11.03.2022Examination requested  [2022/25]
16.02.2024Amendment by applicant (claims and/or description)
16.02.2024Date on which the examining division has become responsible
Fees paidRenewal fee
11.03.2022Renewal fee patent year 03
05.07.2023Renewal fee patent year 04
04.07.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2009064696  (UNIV CALIFORNIA [US], et al) [X] 1-15 * See the examples *;
 [X]  - ZHANG XIAO-XIANG ET AL, "Synthesis, characterization, and in vitro transfection activity of charge-reversal amphiphiles for DNA delivery", BIOCONJUGATE CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 22, ISSN 1043-1802, (20110420), pages 690 - 699, (20110401), XP002659811 [X] 1-15 * See, e.g. figures 1 and 3 *
 [X]  - KANG JI HEE ET AL, "Self-Assembling Lipid-Peptide Hybrid Nanoparticles of Phospholipid-Nonaarginine Conjugates for Enhanced Delivery of Nucleic Acid Therapeutics", BIOMACROMOLECULES, US, vol. 18, no. 11, doi:10.1021/acs.biomac.7b01084, ISSN 1525-7797, (20171009), pages 3733 - 3741, URL: https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.7b01084, XP055794024 [X] 1-15 * See figure 2 *

DOI:   http://dx.doi.org/10.1021/acs.biomac.7b01084
International search[X]US5010067  (HANDLEY DEAN A [US], et al) [X] 7-14 *Abstract & Claims*;
 [X]WO9941266  (UNIV EMORY [US], et al) [X] 7-10 *Abstract & Claims*;
 [X]WO0059474  (ISIS PHARMACEUTICALS INC [US], et al) [X] 7-14 *Claims*;
 [X]US2002035082  (GRINSTAFF MARK W [US], et al) [X] 7-10 *Examples & Claims*;
 [X]WO2004062593  (ELAN PHARM INC [US], et al) [X] 7-10 *Abstract & Claims*;
 [X]WO2005007810  (GRINSTAFF MARK W [US], et al) [X] 7-14 *Abstract, Examples, & Claims*;
 [X]WO2007073489  (UNIV BOSTON [US], et al) [X] 7-14 *Abstract, Examples, & Claims*;
 [X]WO2009064696  (UNIV CALIFORNIA [US], et al) [X] 7-14 *Claims, Examples & Abstract*;
 [X]US2011059180  (BARTHELEMY PHILIPPE [FR], et al) [X] 7-14 *Examples 1-2, Claims & Abstract*;
 [X]WO2011130674  (UNIV WASHINGTON [US], et al) [X] 7-10 *Table B*;
 [X]WO2014039501  (LAUREN SCIENCES LLC [US]) [X] 7-14 *Table 1 & Abstract*;
 [X]US2014287024  (WANG SHU [US], et al) [X] 7-14 *Examples, Claims & Abstract*;
 [X]US2014369935  (OKAMOTO YOSHIHARU [JP], et al) [X] 7-14 *Examples & Claims*;
 [X]WO2015110957  (DE BEER JOEL [CH]) [X] 7-14 *Claims & Abstract*;
 [X]WO2015121627  (KRATOS ANALYTICAL LTD [GB]) [X] 7-10 *Table 1*;
 [X]WO2017099823  (MODERNATX INC [US]) [X] 7-14 *pages 97-143 & Claims*;
 [X]WO2017201076  (UNIV TEXAS [US]) [X] 7-14 *Abstract, Examples, & Claims*;
 [PX]WO2019246203  (UNIV TEXAS [US]) [PX] 7-14 *Claims*;
 [PX]WO2020051223  (UNIV TEXAS [US]) [PX] 7-14 *par. [00136]-[00142], Claims & Abstract*;
 [X]  - ZHANG et al., Bioconj. Chem., (20110000), vol. 22, pages 690 - 699, XP002659811 [X] 7-14 *Abstract, Fig. 1-3*
 [X]  - NAVARRO et al., Drug Deliv. Transl. Res., (20110000), vol. 1, pages 25 - 33, XP055539074 [X] 7-14 *Abstract & Fig. 1*

DOI:   http://dx.doi.org/10.1007/s13346-010-0004-0
 [X]  - KOHLI et al., Chem. Phys. Lipids, (20120000), vol. 165, pages 252 - 259, XP028458891 [X] 7-14 * . *Abstract & Fig. 1*

DOI:   http://dx.doi.org/10.1016/j.chemphyslip.2012.01.005
 [X]  - IVANOVA et al., Org. Biomol. Chem., (20130000), vol. 11, pages 7164 - 7178, XP055794019 [X] 7-14 * . *Abstract & Scheme 1*

DOI:   http://dx.doi.org/10.1039/c3ob40442k
 [X]  - STUBIGER et al., Anal. Chem., (20140000), vol. 86, pages 6401 - 6409, XP055187441 [X] 7-10 * . *Scheme 1*

DOI:   http://dx.doi.org/10.1021/ac500719u
 [X]  - VENDITTO et al., Chem. Commun., (20140000), vol. 50, pages 9109 - 9111, XP055794021 [X] 7-14 * . *Abstract & Scheme 1*

DOI:   http://dx.doi.org/10.1039/C4CC02866J
 [X]  - GAO et al., Langmuir, (20160000), vol. 32, pages 1601 - 1610, XP055794022 [X] 7-10 * . *Abstract & Fig. 1(b)*

DOI:   http://dx.doi.org/10.1021/acs.langmuir.6b00035
 [X]  - KANG et al., Biomacromol., (20170000), vol. 18, pages 3733 - 3741, XP055794024 [X] 7-14 * . *Abstract & Fig. 2*

DOI:   http://dx.doi.org/10.1021/acs.biomac.7b01084
 [X]  - AIKAWA et al., ACS Omega, (20170000), vol. 2, pages 5803 - 5812, XP055794034 [X] 7-10 * . *Abstract & Fig. 1*

DOI:   http://dx.doi.org/10.1021/acsomega.7b00574
 [X]  - TEMPRANA et al., PLOS One, (20170000), vol. 12, no. 10, pages 1 - 25, XP055794026 [X] 7-14 * Abstract*

DOI:   http://dx.doi.org/10.1371/journal.pone.0186194
 [X]  - MAJARIKAR et al., J. Photopol. Sci. Tech., (20190000), vol. 32, no. 1, pages 107 - 113, XP055794029 [X] 7-10 * . *Abstract, Sec. 2.1-2.2*

DOI:   http://dx.doi.org/10.2494/photopolymer.32.107
 [X]  - WANG et al., Langmuir, (20190000), vol. 35, pages 1672 - 1681, XP055794030 [X] 7-10 * . * Abstract*

DOI:   http://dx.doi.org/10.1021/acs.langmuir.8b02979
 [X]  - LIU et al., Langmuir, (20190000), vol. 35, pages 11217 - 11224, XP055794032 [X] 7-10 * . * Abstract*

DOI:   http://dx.doi.org/10.1021/acs.langmuir.9b00677
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.